Geneos Wealth Management’s Fidelity Blue Chip Growth ETF FBCG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$507K Buy
10,107
+7,952
+369% +$423K 0.01% 698
2025
Q4
$118K Buy
+2,155
New +$117K ﹤0.01% 1097
2024
Q1
Sell
-4,749
Closed -$158K 2156
2023
Q4
$158K Hold
4,749
0.01% 726
2023
Q3
$138K Hold
4,749
0.01% 779
2023
Q2
$141K Sell
4,749
-956
-17% -$25.7K 0.01% 771
2023
Q1
$145K Hold
5,705
0.01% 737
2022
Q4
$120K Hold
5,705
0.01% 776
2022
Q3
$122K Hold
5,705
0.01% 745
2022
Q2
$124K Hold
5,705
0.01% 926
2022
Q1
$172K Sell
5,705
-2,599
-31% -$77.9K 0.01% 860
2021
Q4
$287K Buy
8,304
+221
+3% +$7.65K 0.01% 743
2021
Q3
$264K Buy
8,083
+7,352
+1,006% +$245K 0.01% 751
2021
Q2
$24K Hold
731
﹤0.01% 1815
2021
Q1
$22K Hold
731
﹤0.01% 2028
2020
Q4
$21K Buy
+731
New +$19.4K ﹤0.01% 1866

Other funds holding FBCG

Geneos Wealth Management's FBCG Position: Q1 2026 in Review

Geneos Wealth Management increased its Fidelity Blue Chip Growth ETF (FBCG) stake by 369% in Q1 2026, buying an estimated $423K and bringing the position to 10,107 shares worth $507K. The position accounts for 0.01% of the portfolio, ranked #698.

Geneos Wealth Management first reported a position in FBCG in Q4 2020 and has held it in 15 quarters since. 266 funds tracked by Wall St. Rank hold FBCG as of Q1 2026.

  • Geneos Wealth Management held 10,107 shares of Fidelity Blue Chip Growth ETF worth $507K as of Q1 2026.
  • Geneos Wealth Management bought 7,952 Fidelity Blue Chip Growth ETF shares in Q1 2026, an estimated $423K.
  • Fidelity Blue Chip Growth ETF made up 0.01% of Geneos Wealth Management's portfolio in Q1 2026, its #698 holding.
  • Geneos Wealth Management first reported a position in Fidelity Blue Chip Growth ETF in Q4 2020 and has held it in 15 quarters since.
  • 266 funds tracked by Wall St. Rank held Fidelity Blue Chip Growth ETF as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.